CagriSema vs MIC + L-Carnitine + B12
A side-by-side research comparison of CagriSema and MIC + L-Carnitine + B12 across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | CagriSema | MIC + L-Carnitine + B12 |
|---|---|---|
| Full name | CagriSema (Cagrilintide + Semaglutide) | Lipotropic Injection Blend (Methionine, Inositol, Choline + L-Carnitine + B12) |
| Category | Weight Management | Weight Management |
| Status | Phase 3 Clinical Trial | Compounded medication |
| Mechanism | Dual-pathway activation: cagrilintide mimics amylin to activate area postrema satiety centers, while semaglutide activates GLP-1 receptors for complementary appetite suppression. | Methionine aids fat breakdown and detoxification. Inositol helps redistribute body fat and improves insulin signaling. Choline prevents fat deposits in the liver. L-Carnitine shuttles fatty acids into mitochondria for oxidation. B12 supports energy metabolism and red blood cell formation. |
| Molecular weight | Combination product | Blend (multiple active compounds) |
| Half-life | 7 days (both components) | Variable by component; B12 ~6 days, L-Carnitine ~17 hours |
| Bioavailability | High (SubQ) | ~100% (intramuscular injection) |
| Typical dose | Cagrilintide 2.4mg + Semaglutide 2.4mg | 1 mL injection (standardized blend) |
| Frequency | Once weekly | 1-2x weekly |
| Route | Subcutaneous | Intramuscular injection |
CagriSema reported benefits
- Enhanced weight loss vs monotherapy
- Dual appetite suppression
- Convenient single injection
- Improved metabolic parameters
- Potential 20-25% weight loss
MIC + L-Carnitine + B12 reported benefits
- Enhanced fat metabolism
- Increased energy levels
- Liver support and detoxification
- Improved mood and mental clarity
- Support for B12 deficiency
Related comparisons
Research and educational reference only. Not medical advice.